cdmo.directory
← Compare landing

Charles River Cell & Gene Therapy vs Dr. Reddy's Laboratories

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/criver/drreddys

CategoryCharles River Cell & Gene TherapyDr. Reddy's Laboratories
Listed sitecdmocdmo
SummaryCharles River provides discovery, development, and manufacturing services across the drug development continuum, including cell and gene therapy capabilities.Integrated global pharmaceutical company manufacturing generics, APIs, biosimilars, and innovative medicines across 66 countries with capabilities in small molecule and biologics development and manufacturing.
Services
  • CMC Regulatory Submission Support
  • Quality Control Testing
  • Technology Transfer
  • Formulation Development
  • Process Development
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Biologics Development & Manufacturing
  • API Synthesis & Manufacturing
  • Upstream Processing
  • Downstream Processing
  • CMC Analytical Development
  • Stability Testing & Storage
  • Cell-Line Development
  • Microbial Fermentation
  • Small Molecule Development & Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Cell Therapy Manufacturing
  • Process Development
  • Formulation Development
  • CMC Analytical Development
  • Technology Transfer
  • CMC Regulatory Submission Support
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Stability Testing & Storage
  • Quality Control Testing
  • Oral Solid Dosage Manufacturing
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
Indications
  • Oncology
  • Immunology
  • Neurology
  • Oncology
  • Immunology
  • Metabolic
  • Infectious Disease
  • Respiratory
  • Gastroenterology
  • Women's Health
Locations
  • Headquarters, United States
  • North America, North America
  • Europe, Europe
  • Asia, Asia
  • Headquarters, India
  • Global Headquarters, India
  • Americas, Americas
  • Europe, Europe
  • Asia, Asia
  • Australia, Oceania, Australia
  • Africa, Africa
  • Global Headquarters, Hyderabad, Telangana, India
  • Global presence, Multiple (66 countries)
Certifications
  • FDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • PMDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: Retrogenix® platform data support
  • PMDA · Identifier: Retrogenix® platform data support
  • DCGI · Identifier: DCGI-approved
  • USFDA · Identifier: USFDA-approved
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.